Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: A naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine

Journal of Clinical Psychopharmacology

Volumn 34, Issue 1, 2014, Pages 124-128

  Walther, Sebastian ^a   Moggi, Franz ^a,b   Horn, Helge ^a   Moskvitin, Konstantin ^a   Abderhalden, Christoph ^a   Maier, Nadja ^a   Strik, Werner ^a   Müller, Thomas J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Aggressive behavior; Agitation; Haloperidol; Olanzapine; Rapid tranquilization; Risperidone; Schizophrenia

Indexed keywords

BIPERIDEN; DIAZEPAM; HALOPERIDOL; OLANZAPINE; RISPERIDONE;

ADULT; AGITATION; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; MALE; PATIENT DROPOUTS; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SEX DIFFERENCE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891745331     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000050     Document Type: Article

References (28)

1. Battaglia J. Pharmacological management of acute agitation. Drugs. 2005;65(9):1207-1222.
2. Buckley P, Citrome L, Nichita C, et al. Psychopharmacology of aggression in schizophrenia. Schizophr Bull. 2011;37(5):930-936.
3. Abderhalden C, Needham I, Dassen T, et al. Frequency and severity of aggressive incidents in acute psychiatric wards in Switzerland. Clin Pract Epidemiol Ment Health. 2007;3:30.
4. Cornaggia CM, Beghi M, Pavone F, et al. Aggression in psychiatry wards: a systematic review. Psychiatry Res. 2011;189(1):10-20.
5. Serper MR, Goldberg BR, Herman KG, et al. Predictors of aggression on the psychiatric inpatient service. Compr Psychiatry. 2005;46(2):121-127.
6. Krakowski M, Czobor P. Gender differences in violent behaviors: relationship to clinical symptoms and psychosocial factors. Am J Psychiatry. 2004;161(3):459-465.
7. Citrome L. Interventions for the treatment of acute agitation. CNS Spectr. 2007;12(8 suppl 11):8-12.
8. Kreyenbuhl J, Buchanan RW, Dickerson FB, et al. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull. 2010;36(1):94-103.
9. Alexander J, Tharyan P, Adams C, et al. Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry. 2004;185:63-69.
10. Currier GW, Simpson GM. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry. 2001;62(3):153-157.
11. Fang M, Chen H, Li LH, et al. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia. Int Clin Psychopharmacol. 2012;27(2):107-113.
12. Lim HK, Kim JJ, Pae CU, et al. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study. Neuropsychobiology. 2010;62(2):81-86.
13. Hsu WY, Huang SS, Lee BS, et al. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan. J Clin Psychopharmacol. 2010;30(3):230-234.
14. Kinon BJ, Stauffer VL, Kollack-Walker S, et al. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. J Clin Psychopharmacol. 2008;28(6):601-607.
15. Villari V, Rocca P, Fonzo V, et al. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2):405-413.
16. Agid O, Kapur S, Warrington L, et al. Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders. Schizophr Res. 2008;102(1-3):241-248.
17. Huf G, Coutinho ES, Adams CE. Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ. 2007;335(7625):869.
18. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
19. Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr Bull. 1990;16(3):537-545.
20. Wright P, Birkett M, David SR, et al. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry. 2001;158(7):1149-1151.
21. GuyW. ECDEUAssessmentManual for Psychopharmacology. Rockville, MD: US Department of Health, Education and Welfare; 1976.
22. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11-19.
23. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154:672-676.
24. Wilhelm S, Schacht A, Wagner T. Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: results of an observational trial. BMC Psychiatry. 2008;8:61.
25. Swanson JW, Swartz MS, Elbogen EB, et al. Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone. J Clin Psychiatry. 2004;65(12):1666-1673.
26. Kinon BJ, Roychowdhury SM, Milton DR, et al. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia. J Clin Psychiatry 2001;62(suppl 2):17-21.
27. Lambert M, Huber CG, Naber D, et al. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder. Pharmacopsychiatry. 2008;41(5):182-189.
28. Binder RL, McNiel DE. The relationship of gender to violent behavior in acutely disturbed psychiatric patients. J Clin Psychiatry. 1990;51(3):110-114.